HOWL
Werewolf Therapeutics Inc

1,049
Mkt Cap
$51.94M
Volume
275,899.00
52W High
$2.38
52W Low
$0.595
PE Ratio
-0.66
HOWL Fundamentals
Price
$1.08
Prev Close
$1.07
Open
$1.09
50D MA
$1.33
Beta
1.85
Avg. Volume
598,047.95
EPS (Annual)
-$1.63
P/B
1.71
Rev/Employee
$40,978.26
Loading...
Loading...
News
all
press releases
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells $16,070.96 in Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 16,568 shares of the business's stock in a transaction dated Friday, December 5th. The stock was sold at an...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Director Sells $31,951.62 in Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 36,726 shares of the business's stock in a transaction on Wednesday, December 3rd. The stock was sold at an...
MarketBeat·6d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 39,096 Shares
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 39,096 shares of Werewolf Therapeutics stock in a transaction dated Monday, December 1st. The stock was sold at an...
MarketBeat·9d ago
News Placeholder
Luke Evnin Sells 26,411 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 26,411 shares of the stock in a transaction on Thursday, November 20th. The shares were sold at an average price...
MarketBeat·20d ago
News Placeholder
Luke Evnin Sells 58,372 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 58,372 shares of the business's stock in a transaction that occurred on Thursday, November 13th. The stock was...
MarketBeat·23d ago
News Placeholder
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 26,101 Shares of Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 26,101 shares of the business's stock in a transaction on Wednesday, November 12th. The shares were sold at an...
MarketBeat·28d ago
News Placeholder
Luke Evnin Sells 31,172 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 31,172 shares of the firm's stock in a transaction dated Monday, November 10th. The stock was sold at an average...
MarketBeat·28d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 35,818 Shares
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) Director Luke Evnin sold 35,818 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of...
MarketBeat·28d ago
News Placeholder
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Bioventures 2014 L.P. Mpm Sells 55,810 Shares
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 55,810 shares of Werewolf Therapeutics stock in a transaction on Tuesday, November 11th...
MarketBeat·28d ago
News Placeholder
Bioventures 2014 L.P. Mpm Sells 68,480 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL - Get Free Report) major shareholder Bioventures 2014 L.P. Mpm sold 68,480 shares of the business's stock in a transaction dated Friday, November 7th. The...
MarketBeat·28d ago

Latest HOWL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.